Viewing Study NCT02468557


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2026-02-10 @ 12:49 AM
Study NCT ID: NCT02468557
Status: TERMINATED
Last Update Posted: 2021-04-02
First Post: 2015-06-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: Gilead Sciences
Organization: